Skip to content

Effects of rivastigmine on biperiden-induced memory impairment in healthy adults: an EEG study.

Effects of rivastigmine on biperiden-induced memory impairment in healthy adults: an EEG study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22111
Enrollment
20
Registered
2007-10-23
Start date
2007-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-term memory.

Interventions

Participants will participate on 4 separate test days and will be administered either rivastigmine, biperiden, a combination, or a placebo. The order of treatment will be counterbalanced.

Sponsors

Anke Sambeth
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female; 2. 18 to 35 years of age; 3. healthy (i.e. absence of all exclusion criteria); 4. body mass index between 18.5 and 30; 5. willingness to sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. History of cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal, haematological, or psychiatric ilness; 2. excessive drinking (> 20 glasses of alcohol containing beverages a week); 3. pregnancy or lactation; 4. use of medication other than oral contraceptives; 5. use of recreational drugs from 2 weeks before the experiment until the end of the study; 6. any sensory or motor deficits which could reasonably be expected to affect test performance; 7. having a first-degree relative with a psychiatric disorder.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the behavioral score on a set of memory paradigms, namely a verbal learning task, a picture memory task, and a spatial memory task. Furthermore, the brain activity (EEG and event-related potentials) will be recorded during those tasks.

Secondary

MeasureTime frame
The behavioral response and brain activity during a choice reaction time task is recorded in order to find out whether the medication also has sedative effects.

Contacts

Public ContactAnke Sambeth

Faculty of Psychology Dept. of Neuropsychology and Psychopharmacology PO Box 616

anke.sambeth@psychology.unimaas.nl0031-(0)43-3881757

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)